8 completed, 8 recruiting, 6 not yet recruiting, 1 active not recruiting. 8 Not applicable, 2 Early Phase 1, 2 Phase 2, 2 Phase 3, 1 Phase 1.
Follow Crohn's Disease (CD): new trials by email Literature Review of Crohn's Disease (CD) trials Research Report on Crohn's Disease (CD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease Catered Anti-Inflammatory Diet, Diet Guidance for Usual Diet - Crohn's Disease, Active, Crohn's Disease (CD) | Not applicable | Recruiting | University of Miami | 122 | 2026-09-16 | 2026-09-24 |
| Virtual Group Therapy for IBD Patients With Anxiety and Depression Group Psychotherapy Intervention - Crohn's Disease (CD), Ulcerative Colitis (UC) | Not applicable | Not yet recruiting | University of Chicago | 16 | 2026-09-01 | 2026-09-01 |
| Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD IOUS-guided margin selection - Crohn's Disease (CD) | Not applicable | Recruiting | The Cleveland Clinic | 22 | 2026-09-01 | 2026-08-27 |
| Accurately Profiling the Changes and Functions of Key Microflora in the Whole Intestinal Microenvironment Based on the Visual Sampling Capsule Endoscopy in Patients With Inflammatory Bowel Disease Crohn's Disease (CD), Ulcerative Colitis (UC) | Not yet recruiting | Changhai Hospital | 250 | 2026-09-01 | 2026-09-08 | |
| VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission Non-invasive vagus nerve stimulation (nVNS) - Inflammatory Bowel Diseases (IBD), Remission of IBD | Early Phase 1 | Enrolling by invitation | University of Gdansk | 15 | 2026-08-07 | 2026-08-11 |
| A Pilot Study: Micro and NanoPlastics in Association With Crohn's Disease Crohn's Disease (CD) | Not yet recruiting | Mak Wing Yan | 90 | 2026-06-15 | 2026-06-05 | |
| Research on the Whole Process of AI Intelligent Management System for the Diagnosis and Treatment of Inflammatory Bowel Diseases Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn's Disease (CD) | Not yet recruiting | Taichung Veterans General Hospital | 4500 | 2026-06-01 | 2026-05-15 | |
| An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection Guselkumab - Crohn's Disease (CD) | Not yet recruiting | Shanghai 10th People's Hospital | 88 | 2026-04-15 | 2026-04-14 | |
| Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study enteral nutrition - Crohn's Disease (CD) | Not applicable | Recruiting | University of Glasgow | 90 | 2026-03-27 | 2026-04-13 |
| Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD) Acetaminophen, Ibuprofen - Crohn's Disease (CD), Dysmenorrhea Primary | Not applicable | Recruiting | University of North Carolina, Chapel Hill | 24 | 2026-03-18 | 2026-07-14 |
| Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis Ketogenic diet, Carnivore (Lion) Diet - Rheumatoid Arthritis (RA), Crohn's Disease (CD) | Not applicable | Recruiting | Fuller Research Foundation | 160 | 2026-02-17 | 2026-10-05 |
| Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease RD06-05 CART Cell Infusion - Moderate-to-severe Ulcerative Colitis, Crohn's Disease (CD) | Early Phase 1 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 30 | 2025-12-20 | 2025-12-30 |
| Zymfentra (Infliximab-dyyb) REal World Cohort STudy Ulcerative Colitis (UC), Crohn's Disease (CD) | Recruiting | University of North Carolina, Chapel Hill | 200 | 2025-11-20 | 2026-08-05 | |
| Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease anti-TL1A monoclonal antibody, low dose, anti-TL1A monoclonal antibody, medium dose, anti-TL1A monoclonal antibody, high dose - Crohn's Disease (CD) | Phase 2 | Recruiting | Biocad | 204 | 2025-08-14 | 2025-09-17 |
| A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Vedolizumab IV - Crohn's Disease (CD) | Phase 3 | Recruiting | Takeda | 120 | 2022-02-10 | 2026-05-05 |
| The Impact of Time Restricted Feeding in Crohn's Disease Time Restricted Feeding - Crohn's Disease (CD) | Not applicable | Completed | Weill Medical College of Cornell University | 15 | 2021-01-14 | 2023-01-31 |
| Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) Risankizumab, Ustekinumab - Crohn's Disease (CD) | Phase 3 | Active not recruiting | AbbVie | 527 | 2020-09-30 | 2026-04-13 |
| A Real-world Study of Imraldi® Use Adalimumab - Arthritis, Rheumatoid (RA), Axial Spondyloarthritis (axSpA) | Completed | Biogen | 1000 | 2019-06-30 | 2023-04-18 | |
| Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease Inflectra - Inflammatory Bowel Disease (IBD), Crohn's Disease (CD) | Completed | Pfizer | 118 | 2018-02-23 | 2021-03-02 | |
| Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease Inflammatory Bowel Disease (IBD), Crohn's Disease (CD) | Completed | The Royal Wolverhampton Hospitals NHS Trust | 63 | 2016-11-08 | 2020-03-27 |
Showing 20 of 25. Sign in to see all of them.
Crohn Disease (25) · Colitis, Ulcerative (12) · Inflammatory Bowel Diseases (10) · Arthritis, Rheumatoid (3) · Arthritis, Psoriatic (2) · Autoimmune Diseases (2) · Axial Spondyloarthritis (2) · Anxiety Disorders (1) · Congenital Abnormalities (1) · Depression (1) · Fasting (1) · Intermittent Fasting (1) · Margins of Excision (1) · Motor Activity (1) · Spondylitis, Ankylosing (1)
Digestive System Diseases (25) · Gastroenteritis (25) · Gastrointestinal Diseases (25) · Intestinal Diseases (25) · Inflammatory Bowel Diseases (15) · Colitis (12) · Colonic Diseases (12) · Arthritis (3) · Behavior (3) · Connective Tissue Diseases (3) · Immune System Diseases (3) · Joint Diseases (3) · Musculoskeletal Diseases (3) · Rheumatic Diseases (3) · Skin and Connective Tissue Diseases (3)
Acetaminophen (1) · Adalimumab (1) · Cholecalciferol (1) · Diet (1) · Diet, Ketogenic (1) · Enteral Nutrition (1) · Fecal Microbiota Transplantation (1) · Ibuprofen (1) · Infliximab (1) · Ustekinumab (1) · guselkumab (1) · risankizumab (1) · upadacitinib (1) · vedolizumab (1)
AbbVie (2) · University of North Carolina, Chapel Hill (2) · Biocad (1) · Biogen (1) · Changhai Hospital (1) · Children's Mercy Hospital Kansas City (1) · Fuller Research Foundation (1) · Mak Wing Yan (1) · Pfizer (1) · Shanghai 10th People's Hospital (1) · Taichung Veterans General Hospital (1) · Takeda (1) · The Cleveland Clinic (1) · The Royal Wolverhampton Hospitals NHS Trust (1) · UCB BIOSCIENCES, Inc. (1)
United States (15) · United Kingdom (6) · Belgium (4) · Canada (4) · China (4) · Italy (4) · Poland (4) · Spain (4) · Czechia (3) · Germany (3) · Hungary (3) · Israel (3) · Slovakia (3) · Australia (2) · France (2)
Alka Goyal, MD (1) · Alyse Bedell, PhD, CST (1) · Arina V Zinkina-Orikhan (1) · Dana J Lukin, MD, PhD (1) · David Limsui, MD (1) · Erica J Brenner, MD, MSCR (1) · Hans Herfarth, MD, PhD (1) · Helen Steed (1) · Joyce Wing Yan Mak (1) · Oriana M Damas, MD, MSCTI (1) · Ross Cranston, M.D. (1)
PMID 24312659, PMID 31483437, PMID 33359090, PMID 34968730, PMID 34995529, PMID 35296993, PMID 37632666, PMID 39018531, PMID 40357993, PMID 41344313, PMID 42479626
2015 (1), 2023 (1), 2025 (1), K23DK146181 (1)